Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead/Kite Pricing For Yescarta Undercuts Novartis's CAR-T Kymriah

T-cells attacking cancer_1200x675

Additional Topics

Approvals Business Strategies Pricing Strategies Drug Safety Commercial Cancer BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window